Asset Strategy Leader, R&D Aesthetics

About the role

The Asset Strategy Leader is an experienced and established leader with the ability to influence across multiple functions and levels within Abbvie who serves as the matrix leader with overall accountability for an asset from discovery to end of life cycle. He / she guides and directs the creation and execution of a comprehensive asset strategy and phase appropriate brand strategies for one or multiple assets.

Responsibilities

• Chairs an Asset Strategy Team (AST). In this capacity, serves as the enterprise leader who is the projects primary point of contact for Pipeline Governance and senior management.
• Has a broad vision for the asset and leads the effort to create, articulate and gain endorsement of an integrated cross-functional Global Asset Strategy and Brand Strategy for all aspects of product development, commercialization and lifecycle management and ensures timely, multidirectional and comprehensive interactions with Pipeline Governance within the Pipeline Operating Model, including close liaison with the key governance bodies of Aesthetics Device Governance Board, Tri-Function Review and other ad hoc governance requests within Abbvie.
• Ability to put asset recommendations in context of Abbvies enterprise objectives
• Maintains primary responsibility for the ensuing deliverables, including a functionally aligned Global Asset Strategy and Product Development Plan (PDP).
• Reviews and analyzes emerging data objectively to drive team toward recommendations that highlight opportunities, address potential risks and proactively provide appropriate mitigations.
• Buils strong, collaborative peer-to-peer relationships with governance team members and executives to enable optimal timely, multi-directional, and comprehensive interactions with PCM Governance at pre-specified milestones and as program issues or opportunities arise.
• Ensures that the AST continually validates the viability of the program from a scientific and commercial perspective. Develops clear, prospective Go/No-Go decision points and serves as a champion for the program, using objectivity and judgment to analyze, interpret and present data to Pipeline Governance and senior management.
• Strategic advisor to cross-functional teams (e.g., Global Commercial Team, Global Brand Team, CMC, Integrated evidence strategy team, Value and Access team, Regulatory strategy, etc.).
• Establishes close, ongoing ties with across Asset and deliverable team members and enables a culture of inclusivity, psychological safety, and empowerment. Maintains a function-neutral position in prioritizing actions and making decisions, with an eye toward optimizing asset and portfolio value in a timely and high-quality fashion. Coaches and mentors team members, consistent with the High Performing Teams (HPT) model. Enables the AST to focus on strategy and decision-making, and optimal communication of issues to supporting teams and leadership.
• Represents the AST at interactions with external parties (e.g., Advisory Boards, regulatory interactions) when these engagements require broad cross-functional contributions. Exhibits exceptional executive presence and clear communication with all levels of management.
• Works with team members to maintain a comprehensive and up-to-date understanding of the competitive environment in the field and to assess for potential impact on ongoing programs. Stays abreast of professional information, industry trends, and emerging technology through conferences, medical literature, and training to augment expertise in drug development and the pharmaceutical industry. Develops a comprehensive understanding of how AbbVies assets are positioned relative to competitor assets

Qualifications

• Bachelors Degree required; Advanced (Doctoral-level or MBA) degree highly preferred.
• Relevant experience (minimum of 5 years to 8 years; 10+ years preferred) as a leader in a pharmaceutical/biotech Commercial, R&D, Regulatory or Operations setting; deep expertise in a relevant discipline associated with drug development and /or commercialization and ideally experienced in multiple areas of the industry, often with multiple therapy areas, phases of development.
• Demonstrated a high-level of strategic thinking, leadership, and problem-solving, with the ability to swiftly apply new knowledge to asset strategy and enterprise priorities.
• Ideally experienced across multiple device product development, particular emphasis on facial aesthetics programs.
• Individuals with who have had the experience of following a single asset and associated brands through all the phases of the development and commercialization of a single asset will be preferred but achieving as an aggregate of experience across multiple assets is also acceptable.
• Demonstrated ability to lead. motivate and elicit top performance from teams in a cross functional, highly matrixed pharmaceutical/biotech environment, preferably with global scope, in any discipline which involves a broad understanding of all phases of drug commercialization.
• Ability to objectively exercise judgment and create pragmatic solutions to address complex cross-functional problems, and to be accountable for obtaining stakeholder advice to make informed decisions, to move a program forward in the face of uncertainty or incomplete data. Can stand alone or take unpopular decisions to ensure appropriate organizational decisions.
• Demonstrated ability to communicate with and influence senior executives
• Experience of how different elements (discovery, development, regulatory, commercial etc.) fit together in the drug commercialization lifecycle and has demonstrable ability to rapidly assimilate new knowledge of relevance to drug development and commercialization
• Deep expertise in the strategy and execution for commercialization of drugs including R&D, Regulatory, Commercial and /or Manufacturing
• Ability to objectively exercise judgment and create pragmatic solutions to address complex cross-functional problems and to be accountable for obtaining stakeholder advice to make informed decisions, in order to move a program forward in the face of uncertainty or incomplete data. Ability to delegate appropriate accountability and decision-making to supporting teams and functions.